ATLANTA, GA, United States, via ETELIGIS INC., 02/04/2015 – – Cerora, Inc., a StartUp Health Academy, GE Entrepreneurship program and Ben Franklin Technology Partners-Northeastern Pennsylvania company, participated yesterday at NeuroLaunch Investor Demo Day in Atlanta as their CEO Adam J. Simon participated on an expert panel on the future of neuro-wearable devices. “We are delighted to have participated in the NeuroLaunch Investor Demo Day and excited about the brain centric focus that NeuroLaunch is promoting” said CEO Adam Simon. “It is an excellent opportunity to meet more members of the neurotechnology community including other startups and neuroscience minded investors.” In addition to participation on the neuro-wearables panel, Dr. Simon presented Cerora’s investment opportunity to the NeuroLaunch investors in attendance at the Investor Demo Day. As part of his presentation during the expert panel, Simon conducted a live demonstration of Cerora’s Borealis™ brainwave biosensor solution by remotely examining his own brainwaves and showing the results to the audience on-screen in real time.
Cerora is actively engaging with investors to fund the company’s development plans for the future.
NeuroLaunch’s Investor Demo Day connected investors with the most promising neuro-startups, including NeuroLaunch’s six portfolio companies from their Fall 2014 cohort as well as 22 Poster Showcase companies from around the world. In total with 28 startups participating, Investor Demo day is believed to be the largest single gathering of neuroscience startups ever.
About Cerora, Inc.
Cerora is leading the way in the development and testing of mobile software and hardware technologies required to provide critical, objective, biomarker-based brain function diagnostic information. Located in the high-tech nexus at Ben Franklin Technology Partners of Northeastern Pennsylvania’s Tech Ventures on Lehigh University’s Mountaintop Campus in Bethlehem, Pennsylvania, Cerora has assembled a team of experienced medical scientists and management professionals under the leadership of CEO Adam J. Simon, PhD, a physicist and globally-recognized brain biomarker expert.
NeuroLaunch (www.neurolaunch.com, @neurolaunch, #NeuroLaunch) is the world’s first Neuroscience Startup Accelerator applying the lean early-stage methodology of company acceleration to neuroscience. By cultivating the most promising neuroscience startups and aligning them with resources, they help innovators rapidly bring their neurotechnologies to market where they can help society. The program combines funding, curriculum, mentors and partners to support select portfolio companies.
For additional information, please visit: www.cerora.com
Follow us on twitter: @CeroraInc
SOURCE: Cerora, Inc.